Education
About Us
Working with TipRanks
Follow Us
Stephen Hoffman Insider Profile
4 Followers
Stephen Hoffman, Director at Genocea Biosciences, holds 8.86K shares in Talphera (Ticker: TLPH), holds 31.97K shares in Whitehawk Therapeutics (Ticker: WHWK), holds 1.99M shares in Genocea Biosciences (Ticker: GNCAQ).
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-46.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stephen Hoffman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 11, 2014 - Feb 11, 2015
Return:-20.80%
The most profitable trade made by Stephen Hoffman
Stephen Hoffman's Trading History
Genocea Biosciences
Mar 17, 2015
Director
Informative Buy
5.78M
―
Whitehawk Therapeutics
Nov 14, 2018
CEO, Director
Informative Buy
64.14K
$97.50K
Dicerna Pharma
Feb 05, 2014
―
Uninformative Buy
492.51K
$1.11M
Talphera
Oct 24, 2025
Director
Uninformative Buy
―
$7.15K
List of latest transactions for each holding click on a transaction to see Stephen Hoffman's performance on stock
You May Also Like
Stephen Hoffman insider profile FAQ
What is the percentage of profitable transactions made by Stephen Hoffman?
The percentage of profitable transactions made by Stephen Hoffman is 0%.
What is the average return per transaction made by Stephen Hoffman?
The average return per transaction made by Stephen Hoffman is -46.20%.
What stocks does Stephen Hoffman hold?
Stephen Hoffman holds: GNCAQ, WHWK, DRNA, TLPH stocks.
What was Stephen Hoffman’s latest transaction?
Stephen Hoffman latest transaction was an Uninformative Buy of ―.
What was Stephen Hoffman's most profitable transaction?
Stephen Hoffman’s most profitable transaction was an Informative Buy of GNCAQ stock on February 11, 2014. The return on the trade was -20.80%.
What is Stephen Hoffman's role in Genocea Biosciences?
Stephen Hoffman's role in Genocea Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.